×
Novozymes Inventory 2011-2023 | NVZMY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Novozymes inventory for the quarter ending December 31, 2023 was
$0.527B
, a
2.2% decline
year-over-year.
Novozymes inventory for 2023 was
$0.527B
, a
2.2% decline
from 2022.
Novozymes inventory for 2022 was
$0.539B
, a
13.12% increase
from 2021.
Novozymes inventory for 2021 was
$0.476B
, a
31.61% increase
from 2020.
View More
Novozymes Inventory 2011-2023 | NVZMY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Novozymes inventory for 2023 was
$0.527B
, a
2.2% decline
from 2022.
Novozymes inventory for 2022 was
$0.539B
, a
13.12% increase
from 2021.
Novozymes inventory for 2021 was
$0.476B
, a
31.61% increase
from 2020.
Related Stocks
Company Name
Market
Cap
Linde (LIN)
$211.4B
Sherwin-Williams (SHW)
$94.1B
Ecolab (ECL)
$69.2B
PPG Industries (PPG)
$28.1B
International Flavors & Fragrances (IFF)
$22.7B
Axalta Coating Systems (AXTA)
$8.5B
Celanese (CE)
$7.9B
CSW Industrials (CSWI)
$7B
Element Solutions (ESI)
$6.7B
Balchem (BCPC)
$5.8B
Arcadium Lithium (ALTM)
$5.6B
NewMarket (NEU)
$5.1B
Valvoline (VVV)
$5B
Nissan Chemical (NNCHY)
$4.5B
H B Fuller (FUL)
$4B
Ashland (ASH)
$3.6B
Sensient Technologies (SXT)
$3.2B
Quaker Houghton (KWR)
$2.9B
Hawkins (HWKN)
$2.6B
Minerals Technologies (MTX)
$2.5B
Perimeter Solutions, SA (PRM)
$1.9B
Orbia Advance, S.A.B De C.V (MXCHY)
$1.7B
Ingevity (NGVT)
$1.7B
ELEMENTIS (ELMTY)
$1.3B
DAQO New Energy (DQ)
$1.2B
Orion S.A (OEC)
$1B
Huabao Holdings (HUIHY)
$943M
Westlake Chemical Partners LP (WLKP)
$796M
AdvanSix (ASIX)
$778M
Green Plains (GPRE)
$682M